Conducting studies in over 50 countries and regions, Caidya specializes in oncology and hematology, rare diseases, pediatrics, cell and gene therapy, cardiovascular, and dermatology. It has emerged as ...
This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 ...
Studies highlight BioWave's patented neuro modulation technology as an effective and powerful tool for pain management across diverse settings NORWALK, ...
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 ProgramThe ...
The ASX healthcare sector ended the week ending November 21, 2025 down, following a sharp sell-off as on Wall Street and ...
Institutions like Acıbadem, Memorial, Medicana and Medical Park have combined cost-competitive care, Western-trained ...
A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately ...
Breakthrough interoperability feature, EDC Connect, eliminates redundant workflows between eSource and EDC systems—redefining how clinical trial data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback